Drug · DIN 01984845
BONEFOS
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since March 27, 2018; first marketed December 31, 1992.
- Drug Identification Number (DIN)
- 01984845
- Company (DIN owner)
- Bayer Inc.Elkhart, Indiana, United States
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Clodronic acid M05BA02
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CLODRONATE DISODIUM (CLODRONATE DISODIUM TETRAHYDRATE) | 400 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 31, 2017: NOC 19117Supplement to a New Drug Submission (SNDS) · Update to the warnings & precautions section of the product monograph regarding osteonecrosis of the jaw (onj) warnings in response to an advisement letter
- February 23, 2007: NOC 8609New Drug Submission (NDS) · Manufacturer name change
- February 22, 2005: NOC 6292New Drug Submission (NDS) · Manufacturer name change
- October 20, 2000: NOC 1086New Drug Submission (NDS)
Other DINs named BONEFOS
- DIN 01984837 · Cancelled Post Market